Host-Cell Factors Involved in COVID-19 Infections May Augur Improved Treatments

Researchers at University of California San Diego and UC Riverside have further elucidated the molecular pathway used by the SARS-CoV-2 virus to infect human lung cells, identifying a key host-cell player that may prove a new and enduring therapeutic target for treating COVID-19.

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks